(19)
(11) EP 1 282 441 A2

(12)

(88) Date of publication A3:
04.04.2002

(43) Date of publication:
12.02.2003 Bulletin 2003/07

(21) Application number: 01930475.7

(22) Date of filing: 30.04.2001
(51) International Patent Classification (IPC)7A61K 39/395, A61K 38/17, A61P 31/00, A61P 35/00, A61P 37/00
// C07K14/705, C07K16/28, C07K19/00 , A01K67:027
(86) International application number:
PCT/US0111/735
(87) International publication number:
WO 0108/5209 (15.11.2001 Gazette 2001/46)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 10.05.2000 US 203015 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, IN 46285 (US)

(72) Inventors:
  • HEUER, Josef, Georg
    Indianapolis, IN 46231 (US)
  • LIU, Jinqi
    Plainsboro, NJ 08536 (US)
  • NA, Songqing
    Carmel, IN 46032 (US)
  • SONG, Ho, Yeong
    Carmel, IN 46032 (US)
  • YANG, Derek, Di
    Carmel, IN 46033 (US)

(74) Representative: Kingsbury, Oliver William 
Eli Lilly and Company Limited,Erl Wood Manor,Sunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) TREATING T-CELL MEDIATED DISEASES BY MODULATING DR6 ACTIVITY